Efficacy and Safety of Bevacizumab with Capecitabine and Cisplatin in Patients with Advanced Gastric Cancer

CME test	Downloadable PDF	PowerPoint slides	CME Information and Faculty Disclosures
Read Dr Love's original email (from August 3, 2010)			Subscribe to Dr Love's email alerts

Slides from a presentation at ASCO 2010 and transcribed comments from recent interviews with Jaffer A Ajani, MD (7/9/10) and Richard M Goldberg, MD (6/23/10)

 

Kang Y et al. AVAGAST: A randomized, double-blind, placebo-controlled, phase III study of first-line capecitabine and cisplatin plus bevacizumab or placebo in patients with advanced gastric cancer (AGC). Proc ASCO 2010;Abstract LBA4007.

Go to previous Journal Club